All workshops are being held Sunday, December 3, 2017.
- Tools for Imaging and Assessment of Engineered Tissue
- Women in Science - Translational Development of TERM Women in Tissue Engineering and Regenerative Medicine Luncheon
- Funding, Communication and Negotiation in Academia and Industry
- Cell and Tissue Manufacturing Innovation
There is a significant need for the development and application of novel imaging and assessment technologies for analysis of engineered tissues and biomaterials. Researchers often rely on microscopy of histological and immunohistochemical stained samples. However, a broad range of tools are currently available and new methodologies are continually under development that provide TERMIS with new insights into the performance of their tissue engineering strategies. The goal of the workshop is to provide TERMIS engineers and scientist with information about tools available for analysis and imaging of engineered tissues. The first half of the workshop will involve presentations from industry representatives describing the capabilities of their technologies and the potential for use in TERM. The afternoon session will involve speakers developing and applying new tools that could enhance TERM research programs. The workshop will inform researchers of new tools but also engage researchers from outside the field to new applications for their techniques.
Women in Science - Translational Development of TERM Women in Tissue Engineering and Regenerative Medicine Luncheon
11:00 AM – 2:30 PM
Invited discussants and speakers: The panel will consist of members from TERM industries, TERM entrepreneurs, academic institutions with partnership with TERM industries and start-ups.
TERMIS-AM 2017 will be hosted in North Carolina, one of the hubs for TERM industry. In the last 3 decades, TERM research areas have undergone much advancement and groundbreaking research development. TERM products have been marketed and a lot more are now reaching the clinical trial stage. Meanwhile, research funding agencies around the globe are promoting academic-industry partnership by providing industry collaborative funding, which further fosters partnership between academic institutions and TERM industries.
Women in TERM luncheon at TERMIS-AM 2017 is organized for women who are keen to learn about the opportunities and development of TERM industry as well as research partnership with TERM industry. We aim to discuss:
- Examples of successful partnership
- What matters to academics and industry partnership
- Ways to obtain academic / industry partnership funding
- Career path insight
Each panelist will be given 10 minutes to share their experiences and the remaining time will be allocated for active discussions and questions from the audience. Audience members will also be given the opportunity to network with the speakers and their peers at the luncheon.
Cell and Tissue Manufacturing Innovation
1:00 PM – 3:30 PM
This pre-conference workshop entitled, “Cell and Tissue Manufacturing Innovation” will provide a comprehensive overview of the current stage of manufacturing in tissue engineering and regenerative medicine. Diverse stakeholders and perspectives will be presented that cover academic translational programs, development of standards for regenerative medicine manufacturing, industry perspectives, and government initiatives. The US Federal Government has been supporting Tissue Engineering and Regenerative Medicine for almost three decades, currently at a robust level of $1B per year where the Multi-Agency Tissue Engineering Sciences (MATES) working group provides a long-standing coordination mechanism for these efforts. The session will conclude with a round table discussion from these diverse stakeholders to summarize the key developments and challenges in this important area of cell and tissue manufacturing.
Speaker and talks:
1:00PM – 1:05PM
Joshua Hunsberger, Martha Lundberg, Richard McFarland – Co-chairs
1:05PM – 1:20PM
Academic Translational Programs: Gearing up for Manufacturing
Julie Allickson, Director, Translational Research, Wake Forest School of Medicine
1:20PM – 1:35PM
Developing Standards for Regenerative Medicine Manufacturing
Carl Simon, Project Leader, National Institute of Standards and Technology
1:35PM – 1:50PM
Industry Perspectives on Manufacturing Challenges
Jon Rowley, Founder and Chief Technical Officer, RoosterBio, Inc.
1:50PM – 2:05PM
Body-on-a-chip and Personalized Medicine
Tom Shupe, Assistant Professor, Wake Forest Institute for Regenerative Medicine
2:05PM – 2:15PM
2:15PM – 2:30PM
Government Manufacturing Programs
Lester Martinez-Lopez, Major General (RET), U.S. Army, and Chairman, Medical Technology Enterprise Consortium
2:30PM – 2:45PM
21st Cures Act Bill and Implementation
Amy Patterson, Director, NHLBI Scientific Research Program, Policy, and Strategic Initiatives, National Institutes of Health
2:45PM – 3:00PM
National Academy Regenerative Medicine Forum
Sarah Beachy, Senior Program Officer and Project Director, National Academy of Sciences, Engineering, and Medicine